scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Activation of activating protein 1 during hepatic acute phase response

TL;DR: The complexity of AP-1 hepatic transcription factor responses to humoral regulators with direct hepatocellular effects is demonstrated to demonstrate the coordinated regulation of many genes.
Journal ArticleDOI

Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.

TL;DR: The C-terminal conserved region of T3R alpha contains a recognition surface for GRIP1 or a similar coactivator that facilitates its interaction with the basal transcriptional apparatus, which is important for ligand-dependent transactivation.
Journal ArticleDOI

Regulation of late B cell differentiation by intrinsic IKKα-dependent signals

TL;DR: It is found that IKKαAA B cells mount normal primary antibody responses but do not enter germinal centers, suggesting that the NIK–IKKα–p52 axis is not as linear and exclusive as previous studies suggest, and IKK α possesses critical NF-κB-independent functions in B cells.
Journal ArticleDOI

Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis

TL;DR: Assessment of the role of cytokines and nuclear factor-κB in the transcriptional regulation of transporters in two models of cholestasis, lipopolysaccharide (LPS) administration and bile duct ligation concluded that disparities are not due to the individual activity of TNF-α, IL-1,IL-6, or NF-κBs but to the differences in the mechanism of choledestasis.